-
Details
-
Written by Koorosh Teymoornezhad, Homayoun Alaghehmand, Ghazaleh Daryakenari, Soraya Khafri, Mitra Tabari
-
Parent Category: Year 2016, Volume 8
-
Category: Volume 8, Issue 11, November 2016
-
Hits: 4747
Introduction: Preventive resin restorations (PRR) are the conservative choice for the most common carious lesions in children. Thus, new age flowable resin composites with higher filler content are readily used. The aim of this study was to evaluate the microshear bond strength and microleakage of two flowable resin composites containing different percentages of nano zinc oxide (NZnO) particles, which have proven to have antimicrobial properties.
Methods: This experimental in-vitro study was carried out in the Dental Material Research Center of Babol University of Medical Sciences in 2015. One nanohybrid and one nanofill flowable resin composite were chosen and modified with the incorporation of 1% and 3% Wt NZnO particles. Six groups (n=10, 0%, 1%, and 3%) of resin composite sticks on dental enamel (2×2mm) were prepared to be placed in the microtensile tester. The microshear bond strength magnitude (MPa) was recorded at the point of failure. A class I box (3×0.8×1 mm) was prepared on 60 premolars and filled using the resin composites (6 groups, n=10). The specimens were immersed in a 5% basic fuschin solution and sectioned bucco-lingually to view the microleakage using a stereomicroscope. One-way ANOVA and Tukey tests for microshear and Wilcoxon and Kruskal–Wallis tests for microleakage were used to analyze the data in the IBM SPSS Statistics version 22 software.
Results: The bond strength of the 3% clearfill group significantly decreased while no significant change occurred in the bond strength in other groups. The Z-350 group had significantly lower microleakage as nanoparticles increased. No significant difference was observed in the clearfill group.
Conclusion: Up to 3% Wt incorporation of NZnO particles will not diversely alter the bond strength, but it will be beneficial in providing antimicrobial effects with lower microleakage rates.
Keywords: Dental leakage; Flowable composite; Nanoparticles; Shear strength; Zinc oxide
Air JordanAir Jordan 1 Retro High OG Wmns "Panda" CD0461-007 Women/Men Super Deals, Price: $98.03 - Air Jordan Shoes
The most recent editorial (June 2021)
Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?
An editorial by Dr. Mehrdad Jalalian
Read more.
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
Our previous editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
Read more.
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more:
